Puma Biotechnology (PBYI) Inventory (2017 - 2026)

Puma Biotechnology (PBYI) has 10 years of Inventory data on file, last reported at $8.7 million in Q1 2026.

• Quarterly Inventory fell 0.66% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (down 0.66% YoY) and the FY2025 annual result came in at $5.5 million, down 36.78% from the prior year.
• Inventory advanced to $8.7 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $9.5 million in Q3 2025 to a low of $2.7 million in Q3 2024.
• A 5-year average of $6.9 million and a median of $7.1 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory sank 52.93% — and 2025, when it surged 254.51%.
• Tracing PBYI's Inventory over 5 years: stood at $4.5 million in 2022, then soared by 56.43% to $7.1 million in 2023, then advanced by 23.22% to $8.7 million in 2024, then slumped by 36.78% to $5.5 million in 2025, then soared by 57.62% to $8.7 million in 2026.
• The last three Inventory figures came in at $8.7 million (Q1 2026), $5.5 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.